Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Translation machinery associated 16 homolog pseudogene 2 (TMA16P2) is a processed pseudogene that does not encode a functional protein. Like most pseudogenes, TMA16P2 is a genomic sequence resembling a protein-coding gene, but it has accumulated mutations that prevent it from being transcribed or translated into a functional protein. Pseudogenes such as TMA16P2 may sometimes be transcribed into noncoding RNA and have potential regulatory roles, but there is no evidence of any biological, regulatory, or disease-associated function specifically documented for TMA16P2 to date[2][3][8][1]. TMA16P2 is not a therapeutic target, functional receptor, enzyme, transporter, or transcription factor. Being a pseudogene, it falls under the "Other" category in molecular classifications. There are no established aliases, functional roles, or clinical utilities for TMA16P2[2][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translation machinery associated 16 homolog pseudogene 2 (TMA16P2).